Product image of Montek (Sodium Molybdate (99mo)) supplied by GNH India

Montek

Active Ingredient:
Sodium Molybdate (99mo)
Origin:
EU

Montek (Sodium Molybdate (99mo))

Sodium molybdate, the active ingredient in Montek, is a chemical compound presented as an injectable solution for intravenous and ocular use. It is employed in clinical and research settings where molybdenum supplementation or diagnostic applications are required and may be utilized under medical supervision.

GNH India supplies Montek as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, transplant centres, oncology centres, pharmacies and clinics worldwide.

Manufacturer / TM Owner

Monrol Europe Srl

1
Pack/s
This product is added to your enquiry list

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

A minimum order value applies. Our team will confirm the exact amount or quantity after reviewing your requirements.

Indications & Clinical Uses

Montek (sodium molybdate) is primarily utilized in specialized clinical contexts related to molybdenum metabolism and diagnostic procedures.

  • Molybdenum deficiency assessment: aids in evaluating trace element status in patients.
  • Radiopharmaceutical preparation: serves as a carrier in certain imaging agents.
  • Ocular surgery adjunct: used experimentally to support wound healing.

How It Works

  • Sodium molybdate dissociates to release molybdate ions, which act as essential cofactors for molybdenum‑dependent enzymes such as xanthine oxidase, sulfite oxidase and aldehyde oxidase. By supplying molybdenum, the compound enhances the catalytic activity of these enzymes, influencing purine metabolism, sulfite detoxification and other biochemical pathways that rely on molybdenum as a trace element.

Side Effects

Adverse reactions may occur following intravenous or ocular administration of sodium molybdate.

Common Side Effects

  • Injection site pain: mild discomfort at the site of IV infusion.
  • Erythema: localized redness.
  • Ocular irritation: transient burning or tearing.
  • Headache: mild to moderate.
  • Nausea: occasional gastrointestinal upset.
  • Dizziness: brief sensation of light‑headedness.

Serious or Rare Side Effects

  • Anaphylactic reaction: severe allergic response requiring immediate medical attention.
  • Severe hypersensitivity: rash, swelling, or bronchospasm.
  • Serum uric acid elevation: potential gout flare.
  • Renal impairment: decreased kidney function.
  • Thrombophlebitis: inflammation of veins at infusion site.
  • Vision changes: unexpected loss of visual acuity.

Precautions & Warnings

When using Montek, clinicians should observe standard safety measures and patient‑specific considerations.

  • Assess renal function: evaluate baseline kidney status before IV administration.
  • Monitor for hypersensitivity: watch for rash, pruritus or respiratory difficulty.
  • Check trace element levels: avoid excess molybdenum accumulation.
  • Avoid concomitant high‑dose copper supplements: copper may antagonize molybdenum absorption.
  • Pregnancy and lactation: use only if clearly indicated after risk‑benefit assessment.
  • Store at ambient temperature: keep in original container, protect from moisture and light.

Avoid Interactions

Sodium molybdate may interact with other agents that affect trace element balance or coagulation pathways.

Major Interactions (Avoid)

  • Copper supplements: can reduce molybdenum absorption and efficacy.
  • Anticoagulants: potential additive bleeding risk with intravenous infusion.
  • High‑dose vitamin B12: theoretical competition for cellular uptake.

Moderate Interactions (Monitor Closely)

  • Renally excreted drugs: monitor renal function when co‑administered.
  • Other trace element therapies: adjust dosing to maintain appropriate mineral balance.
  • Contrast agents: observe for additive nephrotoxicity, especially in patients with compromised kidneys.

Frequently Asked Questions

Montek contains sodium molybdate and is used in clinical and research settings to provide molybdenum for trace‑element supplementation, to assist in diagnostic imaging preparations, and occasionally as an adjunct in ocular procedures where molybdenum‑dependent enzymatic activity is beneficial.

Sodium molybdate releases molybdate ions that become cofactors for several key enzymes, such as xanthine oxidase and sulfite oxidase. These enzymes rely on molybdenum to catalyze reactions involved in purine metabolism and detoxification of sulfite, thereby supporting normal cellular function.

The specific dose of Montek is determined by the prescribing clinician based on the intended indication, patient weight, renal function and route of administration. Healthcare professionals set the appropriate regimen and monitor the patient accordingly.

Safety data for sodium molybdate in pregnancy and lactation are limited. It should only be used when clearly needed and after a careful risk‑benefit assessment by the treating physician. Breastfeeding mothers should consult their healthcare provider before use.

To place an order, submit an enquiry on the Montek product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details (including cold‑chain if required) and necessary import documentation.

Montek provides sodium molybdate in a sterile injectable form suitable for intravenous and ocular use, which differs from oral molybdenum supplements that are intended for dietary supplementation. The injectable route allows precise dosing and rapid bioavailability, making it preferable for clinical or diagnostic applications.

Montek should be stored at ambient temperature, below 25 °C, in its original sealed container. Protect the product from moisture, direct sunlight and extreme temperature fluctuations to maintain stability and sterility.

Montek is administered either as an intravenous infusion or as an ocular solution, depending on the clinical need. Administration should be performed by qualified healthcare personnel following aseptic technique and the specific protocol prescribed for the indication.

Serious risks include anaphylactic or severe hypersensitivity reactions, renal impairment, thrombophlebitis at the infusion site, and rare vision changes. Immediate medical attention is required if any signs of severe allergic response or organ dysfunction occur.

Montek should be avoided in patients with known hypersensitivity to sodium molybdate, severe renal impairment, uncontrolled copper overload, or those receiving high‑dose copper supplements without medical supervision. Pregnant or breastfeeding individuals should only use it when clearly indicated by a physician.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated:

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.

Related Products

Other formulations containing Sodium Molybdate (99mo)

A

A
A

A
A

A
A

A

Browse all products →

Ordering Process

Simple, Secure, and Seamless

Learn how our streamlined ordering process guarantees fast, compliant, and reliable access to essential medicines worldwide.

Quote request form

01

Submit Quote Request Form

Tell us what medications you need by filling out our simple form and uploading a valid document.

Price estimate review

02

We Review & Send Estimate

Our licensed pharmacists will verify your details and provide you with a detailed cost estimate.

Secure payment

03

Confirm & Make Payment

Discuss any queries, approve the estimate, and complete your payment.

Worldwide delivery

04

Get Delivered

Your medicines, safely packed and delivered to your door or nearest airport — hassle-free.

Regulatory recognitions

Quality You Can Trust

Our internationally recognized certifications underscore our commitment to safety, quality, and excellence.

SGS GSDP Certification

GSDP Compliant from SGS

URS ISO 9001

URS ISO 9001 Certification

FDA Maharashtra

Licensed by FDA Maharashtra

IEC License DGFT

IEC License issued by DGFT